Inulin and fibersol-2 combined have hypolipidemic effects on high cholesterol diet-induced hyperlipidemia in hamsters

Molecules

Volumn 21, Issue 3, 2016, Pages

  Huang, Wen Ching ^a   Lin, Che Li ^a,b   Hsu, Yi Ju ^a   Chiu, Yen Shuo ^a,b,c   Chen, Yi Ming ^a   Wu, Ming Fang ^d   Huang, Chi Chang ^a   Wang, Ming Fu ^e   McPhee, Derek J ^f  

^a NATIONAL TAIWAN SPORT UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d Z Plus Biotechnology Co   (Taiwan)

^e PROVIDENCE UNIVERSITY   (Taiwan)

^f NONE

Author keywords

High cholesterol diet; Hypolipidemic; Inulin; Lipid profiles; Resistant maltodextrin

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; CHOLESTEROL INTAKE; FAT INTAKE; INULIN; LARD; LIPID; PREBIOTIC AGENT; TRIACYLGLYCEROL;

ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANIMAL; BLOOD; CHOLESTEROL INTAKE; COMBINATION DRUG THERAPY; DIET THERAPY; DIETARY FIBER; DRUG EFFECTS; FAT INTAKE; HAMSTER; HYPERLIPIDEMIAS; LIPID DIET; LIVER; MALE; METABOLISM;

ANIMALS; CHOLESTEROL; CHOLESTEROL, DIETARY; CRICETINAE; DIET, HIGH-FAT; DIETARY FATS; DIETARY FIBER; DRUG THERAPY, COMBINATION; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; INULIN; LIPIDS; LIVER; MALE; PREBIOTICS; TRIGLYCERIDES;

EID: 84963571387     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21030313     Document Type: Article

References (40)

1. Laslett, L.J.; Alagona, P., Jr.; Clark, B.A.; Drozda, J.P., Jr.; Saldivar, F.; Wilson, S.R.; Poe, C.; Hart, M. The worldwide environment of cardiovascular disease: Prevalence, diagnosis, therapy, and policy issues: A report from the American College of Cardiology. J. Am. Coll. Cardiol. 2012, 60, S1-S49.
2. Henk, H.J.; Paoli, C.J.; Gandra, S.R. A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with Hyperlipidemia. Adv. Ther. 2015, 32, 1104-1116.
3. Nelson, R.H. Hyperlipidemia as a risk factor for cardiovascular disease. Prim. Care 2013, 40, 195-211.
4. Shih, C.C.; Wu, J.B.; Jian, J.Y.; Lin, C.H.; Ho, H.Y. (-)-Epicatechin-3-O-β-D-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice. Int. J. Mol. Sci. 2015, 16, 24983-25001.
5. Visavadiya, N.P.; Narasimhacharya, A.V. Asparagus root regulates cholesterol metabolism and improves antioxidant status in hypercholesteremic rats. Evid. Based Complement. Altern. Med. 2009, 6, 219-226.
6. Noland, R.C. Exercise and Regulation of Lipid Metabolism. Prog. Mol. Biol. Transl. Sci. 2015, 135, 39-74.
7. Xie, B.; Liu, A.; Zhan, X.; Ye, X.; Wei, J. Alteration of gut bacteria and metabolomes after glucaro-1,4-lactone treatment contributes to the prevention of hypercholesterolemia. J. Agric. Food Chem. 2014, 62, 7444-7451.
8. Zhang, Z.; Wang, H.; Jiao, R.; Peng, C.; Wong, Y.M.; Yeung, V.S.; Huang, Y.; Chen, Z.Y. Choosing hamsters but not rats as a model for studying plasma cholesterol-lowering activity of functional foods. Mol. Nutr. Food Res. 2009, 53, 921-930.
9. Sullivan, M.P.; Cerda, J.J.; Robbins, F.L.; Burgin, C.W.; Beatty, R.J. The gerbil, hamster, and guinea pig as rodent models for hyperlipidemia. Lab. Anim. Sci. 1993, 43, 575-578.
10. Lee, C.L.; Hung, H.K.; Wang, J.J.; Pan, T.M. Red mold dioscorea has greater hypolipidemic and antiatherosclerotic effect than traditional red mold rice and unfermented dioscorea in hamsters. J. Agric. Food Chem. 2007, 55, 7162-7169.
11. Chen, W.; Fan, S.; Xie, X.; Xue, N.; Jin, X.; Wang, L. Novel PPAR pan agonist, ZBH ameliorates hyperlipidemia and insulin resistance in high fat diet induced hyperlipidemic hamster. PLoS ONE 2014, 9, e96056.
12. Reis, S.A.; Conceição, L.L.; Rosa, D.D.; Dias, M.M.; Peluzio Mdo, C. Mechanisms used by inulin-type fructans to improve the lipid profile. Nutr. Hosp. 2014, 31, 528-534.
13. Holscher, H.D.; Bauer, L.L.; Gourineni, V.; Pelkman, C.L.; Fahey, G.C., Jr.; Swanson, K.S. Agave Inulin Supplementation Affects the Fecal Microbiota of Healthy Adults Participating in a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. J. Nutr. 2015, 145, 2025-2032.
14. Weitkunat, K.; Schumann, S.; Petzke, K.J.; Blaut, M.; Loh, G.; Klaus, S. Effects of dietary inulin on bacterial growth, short-chain fatty acid production and hepatic lipid metabolism in gnotobiotic mice. J. Nutr. Biochem. 2015, 26, 929-937.
15. Rebello, C.J.; Burton, J.; Heiman, M.; Greenway, F.L. Gastrointestinal microbiome modulator improves glucose tolerance in overweight and obese subjects: A randomized controlled pilot trial. J. Diabetes Complicat. 2015, 29, 1272-1276.
16. Ohkuma, K.; Wakabayashi, S. Fibersol-2: A soluble, non-digestible, starch-derived dietary fibre. In Advanced Dietary Fibre Technology; McCleary, B.V., Prosky, L., Eds.; Blackwell Science Ltd.: Oxford, UK, 2001; pp. 509-523.
17. Unno, T.; Nagata, K.; Horiguchi, T. Effects of green tea supplemented with indigestible dextrin on postprandial levels of blood glucose and insulin in human subjects. J. Nutr. Food 2002, 5, 31-39.
18. Yamamoto, T. Effect of indigestible dextrin on visceral fat accumulation. J. Jpn. Soc. Study. Obes. 2007, 13, 34-41.
19. Takagak, K.; Ikeguchi, M.; Artura, Y.; Fujinaga, N.; Ishibashi, Y.; Sugawa-Katayama, Y. The effect of AOJIRU drink powder containing indigestible dextrin on defecation frequency and faecal characteristics. J. Nutr. Food 2001, 4, 29-35.
20. Gilat, T.; Leikin-Frenkel, A.; Goldiner, I.; Juhel, C.; Lafont, H.; Gobbi, D.; Konikoff, F.M. Prevention of diet-induced fatty liver in experimental animals by the oral administration of a fatty acid bile acid conjugate (FABAC). Hepatology 2003, 38, 436-442.
21. Gibson, G.R.; Roberfroid, M.B. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J. Nutr. 1995, 125, 1401-1412.
22. Roberfroid, M.B. Prebiotics and probiotics: Are they functional foods? Am. J. Clin. Nutr. 2000, 71, 1682S-1687S.
23. Ringel-Kulka, T.; Kotch, J.B.; Jensen, E.T.; Savage, E.; Weber, D.J. Randomized, double-blind, placebo-controlled study of synbiotic yogurt effect on the health of children. J. Pediatr. 2015, 166, 1475-1481.
24. Verma, A.; Shukla, G. Synbiotic (Lactobacillus rhamnosus + Lactobacillus acidophilus + inulin) attenuates oxidative stress and colonic damage in 1,2 dimethylhydrazine dihydrochloride-induced colon carcinogenesis in Sprague-Dawley rats: A long-term study. Eur. J. Cancer Prev. 2014, 23, 550-559.
25. Shakeri, H.; Hadaegh, H.; Abedi, F.; Tajabadi-Ebrahimi, M.; Mazroii, N.; Ghandi, Y.; Asemi, Z. Consumption of synbiotic bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type-2 diabetes. Lipids 2014, 49, 695-701.
26. Ooi, L.G.; Ahmad, R.; Yuen, K.H.; Liong, M.T. Lactobacillus gasseri [corrected] CHO-220 and inulin reduced plasma total cholesterol and low-density lipoprotein cholesterol via alteration of lipid transporters. J. Dairy Sci. 2010, 93, 5048-5058.
27. Michael, H.D.; Kevin, C.M.; Cheryl, S.; Sarah, A.T.; Kathleen, B.D. Effects of dietary inulin on serum lipids in men and women with hypercholesterolemia. Nutr. Res. 1998, 18, 503-517.
28. Letexier, D.; Diraison, F.; Beylot, M. Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. Am. J. Clin. Nutr. 2003, 77, 559-564.
29. Causey, J.L.; Feirtag, J.M.; Gahaher, D.D.; Tuqland, B.C.; Slavin, J.L. Effects of dietary inulin on serum lipids, blood glucose and the gastrointestinal environment in hypercholesterolemic men. Nut. Res. 2000, 20, 191-201.
30. St-Onge, M.P.; Farnworth, E.R.; Jones, P.J. Consumption of fermented and nonfermented dairy products: Effects on cholesterol concentrations and metabolism. Am. J. Clin. Nutr. 2000, 71, 674-681.
31. Arora, T.; Sharma, R.; Frost, G. Propionate. Anti-obesity and satiety enhancing factor? Appetite 2011, 56, 511-515.
32. Delzenne, N.M.; Daubioul, C.; Neyrinck, A.; Lasa, M.; Taper, H.S. Inulin and oligofructose modulate lipid metabolism in animals: Review of biochemical events and future prospects. Br. J. Nutr. 2002, 87, 255-259.
33. Rossi, M.; Corradini, C.; Amaretti, A.; Nicolini, M.; Pompei, A.; Zanoni, S.; Matteuzzi, D. Fermentation of fructooligosaccharides and inulin by bifidobacteria: A comparative study of pure and fecal cultures. Appl. Environ. Microbiol. 2005, 71, 6150-6158.
34. Weng, H.; Endo, K.; Li, J.; Kito, N.; Iwai, N. Induction of peroxisomes by butyrate-producing probiotics. PLoS ONE 2015, 10, e0117851.
35. Ooi, L.G.; Liong, M.T. Cholesterol-lowering effects of probiotics and prebiotics: A review of in vivo and in vitro findings. Int. J. Mol. Sci. 2010, 11, 2499-2522.
36. Velagapudi, V.R.; Hezaveh, R.; Reigstad, C.S.; Gopalacharyulu, P.; Yetukuri, L.; Islam, S.; Felin, J.; Perkins, R.; Borén, J.; Oresic, M.; et al. The gut microbiota modulates host energy and lipid metabolism in mice. J. Lipid Res. 2010, 51, 1101-1112.
37. Bäckhed, F.; Ding, H.; Wang, T.; Hooper, L.V.; Koh, G.Y.; Nagy, A.; Semenkovich, C.F.; Gordon, J.I. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 2004, 101, 15718-15723.
38. Huang, W.C.; Chen, Y.M.; Kan, N.W.; Ho, C.S.; Wei, L.; Chan, C.H.; Huang, H.Y.; Huang, C.C. Hypolipidemic effects and safety of Lactobacillus reuteri 263 in a hamster model of hyperlipidemia. Nutrients 2015, 7, 3767-3782.
39. Lee, L.C.; Wei, L.; Huang, W.C.; Hsu, Y.J.; Chen, Y.M.; Huang, C.C. Hypolipidemic Effect of Tomato Juice in Hamsters in High Cholesterol Diet-Induced Hyperlipidemia. Nutrients 2015, 7, 10525-10537.
40. Jukema, J.W.; Liem, A.H.; Dunselman, P.H.; van der Sloot, J.A.; Lok, D.J.; Zwinderman, A.H. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: Results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study. Curr. Med. Res. Opin. 2005, 21, 1865-1874.